Significance of oral administration of sodium perchlorate in planning liver-directed radioembolization

Journal of Nuclear Medicine

Volumn 52, Issue 7, 2011, Pages 1063-1067

  Sabet, Amir ^a   Ahmadzadehfar, Hojjat ^a   Muckle, Marianne ^a   Haslerud, Torjan ^a   Wilhelm, Kai ^a   Biersack, Hans Jürgen ^a   Ezziddin, Samer ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Hepatology oncology; Radioembolization; Sodium perchlorate; SPECT

Indexed keywords

MACROSALB TC 99M; SODIUM PERCHLORATE;

ACCURACY; ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIGESTIVE SYSTEM ULCER; ESOPHAGOGASTRODUODENOSCOPY; FEMALE; FOLLOW UP; HUMAN; LIVER ANGIOGRAPHY; LIVER BLOOD VESSEL; LIVER CANCER; LIVER SCINTISCANNING; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; RADIOEMBOLISM; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPONTANEOUS PORTOSYSTEMIC SHUNT; STOMACH BLOOD FLOW; TREATMENT PLANNING;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL TRANSPORT; EMBOLIZATION, THERAPEUTIC; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; PERCHLORIC ACID; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SODIUM COMPOUNDS; SODIUM PERTECHNETATE TC 99M; STOMACH; TECHNETIUM TC 99M AGGREGATED ALBUMIN;

EID: 79960334344     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.110.083626     Document Type: Article

References (21)

1. Denecke T, Ruhl R, Hildebrandt B, et al. Planning transarterial radioembolization of colorectal liver metastases with yttrium 90 microspheres: evaluation of a sequential diagnostic approach using radiologic and nuclear medicine imaging techniques. Eur Radiol. 2008;18:892-902.
2. 99mTc-MAA preparations. Nuklearmedizin. 1977;16:143-144.
3. McLean JR. Rapid assay for total unbound Tc-99m in preparations of Tc-99m in macroaggregated albumin: concise communication. J Nucl Med. 1978;19:1045-1048. (Pubitemid 8392297)
4. 99mTc-MAA. Int J Nucl Med Biol. 1979;6:142-143.
5. Nolte W, Müller R, Siggelkow H, Emrich D, Hufner M. Prophylactic application of thyrostatic drugs during excessive iodine exposure in euthyroid patients with thyroid autonomy: a randomized study. Eur J Endocrinol. 1996;134:337-341. (Pubitemid 26109413)
6. Wolff J. Transport of iodide and other anions in the thyroid gland. Physiol Rev. 1964;44:45-90.
7. Lawrence JE, Lamm SH, Braverman LE. The use of perchlorate for the prevention of thyrotoxicosis in patients given iodine rich contrast agents. J Endocrinol Invest. 1999;22:405-407. (Pubitemid 29259565)
8. 99mTc-MAA SPECT/CT liver perfusion imaging in treatment planning for 90Y-microsphere selective internal radiation treatment. J Nucl Med. 2010;51:1206-1212.
9. Kennedy A, Nag S, Salem R, et al. Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium. Int J Radiat Oncol Biol Phys. 2007;68:13-23. (Pubitemid 46589861)
10. Carretero C, Munoz-Navas M, Betes M, et al. Gastroduodenal injury after radioembolization of hepatic tumors. Am J Gastroenterol. 2007;102:1216-1220. (Pubitemid 46802020)
11. Murthy R, Nunez R, Szklaruk J, et al. Yttrium-90 microsphere therapy for hepatic malignancy: devices, indications, technical considerations, and potential complications. Radiographics. 2005;25(suppl 1):S41-S55. (Pubitemid 41686061)
12. Ahmadzadehfar H, Biersack HJ, Ezziddin S. Radioembolization of liver tumors with yttrium-90 microspheres. Semin Nucl Med. 2010;40:105-121.
13. 90yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: Technical and methodologic considerations. J Vasc Interv Radiol. 2006;17:1251-1278.
14. 90yttrium- microspheres for inoperable hepatic tumors. Int J Radiat Oncol Biol Phys. 1995;33:919-924.
15. Murthy R, Brown DB, Salem R, et al. Gastrointestinal complications associated with hepatic arterial yttrium-90 microsphere therapy. J Vasc Interv Radiol. 2007;18:553-561. (Pubitemid 46566540)
16. Salem R, Parikh P, Atassi B, et al. Incidence of radiation pneumonitis after hepatic intra-arterial radiotherapy with yttrium-90 microspheres assuming uniform lung distribution. Am J Clin Oncol. 2008;31:431-438.
17. Yip D, Allen R, Ashton C, Jain S. Radiation-induced ulceration of the stomach secondary to hepatic embolization with radioactive yttrium microspheres in the treatment of metastatic colon cancer. J Gastroenterol Hepatol. 2004;19:347-349. (Pubitemid 38338751)
18. Atassi B, Bangash AK, Lewandowski RJ, et al. Biliary sequelae following radioembolization with yttrium-90 microspheres. J Vasc Interv Radiol. 2008;19:691-697.
19. Andros G, Harper PV, Lathrop KA. Pertechnetate-99m localization in man with applications to thyroid scanning and the study of thyroid physiology. J Clin Endocrinol Metab. 1965;25:1067-1076.
20. De La Vieja A, Dohan O, Levy O, Carrasco N. Molecular analysis of the sodium/iodide symporter: impact on thyroid and extrathyroid pathophysiology. Physiol Rev. 2000;80:1083-1105. (Pubitemid 30452012)
21. 99mTc-MAA in radioembolization with 90Y microspheres in patients with hepatocellular cancer. J Nucl Med. 2009;50:688-692.